employed integrated proteogenomic profiling of human CRC liver metastases and demonstrated that elevated COL1A2 expression in hepatic metastatic tissues correlates with shorter overall survival and disease-free survival. This evidence concerns the gene COL1A2 and colorectal carcinoma.